Sildenafil: a definitive NO in COPD

Eur Respir J. 2013 Oct;42(4):893-4. doi: 10.1183/09031936.00108313.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Exercise Tolerance*
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Male
  • Piperazines / therapeutic use*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Purines / therapeutic use
  • Sildenafil Citrate
  • Sulfones / therapeutic use*
  • Vasodilator Agents / therapeutic use*

Substances

  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate